ReviewOphthalmology and therapy2017
A Review of Presbyopia Treatment with Corneal Inlays.
Review in Ophthalmology and therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Small-aperture intracorneal inlay implantation in emmetropic presbyopic patients: a systematic review.Eye (London, England) · 2022Pooled it
- Preservation and Reuse of KLEx Lenticules: From Biobanking to Therapeutic and Refractive Innovations.Bioengineering (Basel, Switzerland) · 2026Review
- Cerebral Hypoperfusion Causes Behavioral Changes and Impairs the Rod Photoreceptor Pathway in the Retina of Aged Mice.Cellular and molecular neurobiology · 2026Article
- Progressive Insights into 3D Bioprinting for Corneal Tissue Restoration.Advanced healthcare materials · 2026Review
- Current Trends in Presbyopia Correction-A Comprehensive Review.Journal of clinical medicine · 2025Review
- FDA approval of aceclidine (Vizz): a new chapter in nonsurgical presbyopia management.Annals of medicine and surgery (2012) · 2025Article
- Demonstration of femtosecond laser induced refractive index change in silk-fibroin hydrogels.Biomedical optics express · 2025Article
- Correction of presbyopia using 0.5% pilocarpine eye drops among Indians.Bioinformation · 2024Article
- Complications of Small Aperture Intracorneal Inlays: A Literature Review.Life (Basel, Switzerland) · 2023Review
- Explantation of KAMRA Corneal Inlay: 10-Year Occurrence and Visual Outcome Analysis.Clinical ophthalmology (Auckland, N.Z.) · 2022Article
- Review of Presbyopia Treatment with Corneal Inlays and New Developments.Clinical ophthalmology (Auckland, N.Z.) · 2022Review
- Vision through Healthy Aging Eyes.Vision (Basel, Switzerland) · 2021Review
- Determination of the Standard Visual Criterion for Diagnosing and Treating Presbyopia According to Subjective Patient Symptoms.Journal of clinical medicine · 2021Article
- A new trifocal corneal inlay for presbyopia.Scientific reports · 2021Article
- Refractive corneal inlay for presbyopia in emmetropic patients in Asia: 6-month clinical outcomes.BMC ophthalmology · 2019Article
- Visual Prognosis after Explantation of a Corneal Shape-Changing Hydrogel Inlay in Presbyopic Eyes.Medical hypothesis, discovery & innovation ophthalmology journal · 2019Article
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prevalence of presbyopia continues to increase every year. The therapeutic approaches to presbyopia cover the spectrum of non-surgical to surgical techniques. With recent advances in biocompatible materials, corneal inlays make a strong case for their place within the treatment spectrum. This article takes a closer look at three of the current corneal inlay models: KAMRA, Raindrop, and Presbia Flexivue Microlens. Each design approach and mode of action is described with data from key clinical trials. Furthermore, the ability to choose the most suitable corneal inlay is presented by comparing each model and identifying their similarities and differences. The article then concludes by touching on the future of corneal inlays, looking at associated conditions and complications and how to manage them, as well as an expert's personal point of view of enhanced ideas for continuing the growth and success of corneal inlays in the market.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.